In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Evotec SE

Finance Watch: October Begins With A VC Mega-Round For Newly Named Iambic

Private Company Edition: Iambic, formerly known as Entos, closed a $100m series B venture capital round to advance its AI-discovered therapeutics. Also, Evozyne raised $81m and Acesion brought in €45m in series B rounds, while Mogrify added $10m to bring its series A to $46m.

Financing Artificial Intelligence

Stock Watch: The Rise Of Biotech Platforms

In a wilderness period for biotech stocks, platform company revenues may offer investors less volatile biotech exposure. They are unlikely to shepherd an exit from the current doldrums, though.

Stock Watch Platform Technologies

AI Driving Innovation: Insights From Exscientia CEO Andrew Hopkins

Andrew Hopkins, founder and CEO of Exscientia, invented and championed an algorithmic approach to drug design and drug discovery. He talks to In Vivo about artificial intelligence in the biopharma industry today and what lies ahead. 

Artificial Intelligence Clinical Trials

Evotec Says Sandoz Deal Is ‘Validation’ Of Biologics Ambitions

In the aftermath of announcing a major collaboration with Sandoz on biosimilars, Evotec’s chief business officer Matthias Evers speaks about how the deal provides “validation” of Just-Evotec’s technology platform, while also outlining the firm’s wider ambitions to enable more efficient development of and broader access to biologics.

C-Suite Speaks Biosimilars
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
    • Gene Therapy, Cell Therapy
    • Drug Discovery Tools
      • Bioinformatics
  • Other Names / Subsidiaries
    • Aptuit
    • Bionamics GmbH
    • Cyprotex PLC
    • DeveloGen AG
    • Euprotec Ltd
    • Evotec AG
    • Evotec BioSystems GmbH
    • Evotec Neurosciences GmbH
    • Evotec BioSystems AG
    • Just Biotherapeutics, Inc.
    • Kinaxo Biotechnologies
    • Compound Focus
    • Renovis
    • Just – Evotec Biologics, Inc.
UsernamePublicRestriction

Register